BGB-A317-30813-101
Terminated
A Study of BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
BeOne Study ID
BGB-A317-30813-101
ClinicalTrials.gov ID
EudraCT or EUCT Number
2023-503996-38
China Drug Trials ID
CTR20233404
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents